Cargando…
Revisiting clinical trials on glycemic control and cardiovascular risk
The most relevant clinical trials, assessing the role of glycemic control in reducing cardiovascular risk, are examined. The UKPDS was the first to address this issue. More recent trials (ACCORD, ADVANCE and VADT) are controversial and evidences did not support that strict glycemic control (reflecte...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761296/ https://www.ncbi.nlm.nih.gov/pubmed/19825201 http://dx.doi.org/10.1186/1758-5996-1-12 |